Also, a Korean clinical data solutions provider has utilised Amazon's genAI to automate medical coding.
The company's FDA-cleared autonomous ultrasound imaging system uses a probe to allow for imaging in resource-limited environments to support trauma medicine.
The Hennessy Institute for Cancer Prevention and Applied Molecular Medicine will utilize CancerIQ’s AI platform for personalized risk assessments and advanced early detection.
Pearl Health primary care providers will be able to refer Medicare patients to Synapticure.
The toolkit aims to help countries examine their readiness to implement artificial intelligence into their public health sector equitably and effectively.
The company connects patients with healthcare advocates who help guide them through their healthcare journey.
The alliance aims to support early-stage entrepreneurs developing AI applications in healthtech, medtech and biotech.
The women's health app will use the funds to expand its workforce in North America and Europe, scale its reach and enhance its technology.
